AstraZeneca PLC (AZN)
Last updated: 2026-10-31 15:09:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
AstraZeneca PLC (AZN) operates in the -- sector and is listed on NYSE. The stock is currently priced at $186.67, with a market capitalization of $270.48B and a P/E ratio of 130.34. Over the past 52 weeks, its price has ranged from $153.41 to $212.71. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$270.48B | |
$183.59 | |
$212.71 | |
$29.96 | |
$174.40 | |
5.00M | |
3.27M | |
130.34 | |
$212.71 | |
$153.41 | |
1.22% | |
2001-12-30 |
AstraZeneca PLC (AZN) Latest Closing Stock Price
AstraZeneca PLC (AZN) last closed at $174.40 as of 2026-10-31 00:01:00, unchanged from the previous close of $174.40.
During the latest regular trading session, AZN traded between $29.96 and $212.71, with a volume of 5.00M shares. The closing price was near the upper end and near the middle of its 52-week range.
AstraZeneca PLC (AZN) 7-Day Stock Price Change
Over the past seven days, AstraZeneca PLC (AZN) moved from $172.57 to $186.67, representing a gain of 8.17% ($14.10).
The stock traded between $167.96 and $188.39 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 3.37 million shares, up versus the previous seven-day period, indicating higher trading activity.
AZN 52-Week Price Position
Position in Range: 56.1%
AZN is currently trading at $186.67, placing it 56.1% of the way from its 52-week low of $153.41 to its 52-week high of $212.71. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is AstraZeneca PLC (AZN)?
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
AstraZeneca PLC Information
| Employees | 96100 |
| CEO | Pascal Claude Roland Soriot |
| Founded | 1992 |
| Exchange | NYSE |
| Company Website |
How to Buy AstraZeneca PLC (AZN) Stock on MEXC
Eligible investors can buy real shares of AstraZeneca PLC (AZN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is AstraZeneca PLC (AZN) stock price today?
2.Is AZN stock going up or down today?
3.What is AZN pre-market price?
4.What is AZN after-hours price?
5.Is AZN stock trading now?
6.Where does AZN sit relative to its 52-week high and low?
7.What sector is AstraZeneca PLC in?
8.What is AstraZeneca PLC's market capitalization and where is it listed?
9.How is AZN valued in terms of P/E ratio and EPS?
10.Does AstraZeneca PLC pay a dividend?
Explore More US Stocks
Search Stocks
AZN Stock Calculator
Estimate the value between AZN shares and USD.
AZN Shares to USD
1.00 AZN shares = 186.67 USD
Calculations are estimates based on the latest available price and are for reference only.


